Healthcare -
Biotechnology - NASDAQ - US
$ 21.98
-1.7 %
$ 16.2 B
Market Cap
-95.57
P/E
SMMT - TOTAL ASSETS
Total Assets SMMT - Summit Therapeutics Inc.
203 M
LAST VALUE
33.79%
2 YEAR CAGR
20.96%
5 YEAR CAGR
33.92%
10 YEAR CAGR